BCH-2763

• Description:

  BCH-2763 is a potent and selective thrombin inhibitor. BCH-2763 has a very high affinity for thrombin (Ki = 0.11 nM) . BCH-2763 can effectively inhibit fibrin formation, platelet aggregation, and free thrombin activity. BCH-2763 can be used for the study of thrombosis[1].

• UNSPSC:

  12352209

• Target:

  Thrombin

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O=C([C@H]1N(CCC1)C([C@H](N)CC2=CC=CC=C2)=O)NCCCCC(NCCCCC(N[C@@H](CC(O)=O)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CCC(O)=O)C(N4[C@@H](CCC4)C(N[C@@H]([C@@H](C)CC)C(N5[C@@H](CCC5)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O

• Molecular Formula:

  C64H93N11O16

• Molecular Weight:

  1272.49

• References & Citations:

  [1]Finkle CD, et al. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban. Thromb Haemost. 1998 Feb;79 (2) :431-8.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported

• CAS Number:

  [204641-27-0]